Welcome Guest
Sign In
Register
Products
Popular Categories
Antibody Search
ELISA Kit Search
Biomolecules
Flow Cytometers
Thermal Cyclers
Microscopes
Transfection Reagents
Featured Products
New Products
Research Areas
ELISA
Western Blot
3D Cell Culture
Digital PCR
Quantitative PCR
Cell and Gene Therapy
In Vivo Models
Resources
eBooks
Bench Tips
Tech Insights
Editorial Articles
News
Product Reviews
Future Lab
White Papers
Infographics
Events
Promotions
Multimedia
Biocompare Webinars
Technologies Transforming Precision Medicine
Immunotherapy
Reproducibility
Transformative Technologies
Podcasts
Bench Tip Videos
All Videos and Webinars
Life Science Webinars
Write a Review
Antibodies
Kits/Reagents
Equipment
Services
Register
Sign In
Biocompare
Products
Cloning and Expression
Library Construction
cDNA Synthesis
RNA
RNA
ATPAF1 siRNA (Human)
ATPAF1 siRNA (Human) from MyBioSource.com
Be the first to write a review!
Supplier Page
Supplier Page from
MyBioSource.com for
ATPAF1 siRNA (Human)
Get Pricing
Description
siRNA to inhibit ATPAF1 expression using RNA interference
Product Specs
Company Info
Reviews
Product Specs
Item
ATPAF1 siRNA (Human)
Company
MyBioSource.com
Price
$365.00
Supplier Page
View Company Product Page
Catalog Number
MBS8220508
Quantity
15 nmol
Applications
RNA Interference (RNAi)
Format
Lyophilized powder
Purity
> 97%
Target
ATPAF1
Molecular Weight
27,438 Da
Species
Human
Host
Synthetic
Immunogen
ATPAF1 siRNA (Human) is a target-specific 19-23 nt siRNA oligo duplexes designed to knock down gene expression
NCBI Full Gene Name
ATP synthase mitochondrial F1 complex assembly factor 1
NCBI Gene Aliases
ATP11, ATP11p
Add to Compare List
MyBioSource.com
P.O. Box 153308
San Diego
,
California
United States
Phone
: 1-888-627-0165 (toll free) or 1-858-633-0165
Fax: 1-858-633-0166
Email: sales@mybiosource.com
Company Profile
Website:
http://www.MyBioSource.com
Reviews
Be the First to Write a Review!
ATPAF1 siRNA (Human) from MyBioSource.com
Supplier Page
View Company Product Page
$365.00
Product Specs
Company Info
Reviews
Back To Top